Smruthi Organics shares fall 8 percent

Bangalore: Smruthi Organics stock was among the top losers after its price fell by nearly 8 percent. After opening the day at Rs. 170, the stock touched its day's low of Rs. 152, before closing trade at Rs. 167.75, with a loss of 7.57 percent. Through the day, 5902 shares of Smruthi Organics were traded in the market, with the P/E ratio of 7.92. The 52 week stock price chart is on the left.

Smruthi Organics is an India-based company. The Company is engaged in the manufacturing of active pharmaceutical ingredients (API) fine and specialty chemicals through synthetic organic chemical technology. The Company's products include Diloxanide Furoate, Norfloxacin, Zidovudine, Ciprofloxacin, Pefloxacin, Metformin Hcl, Amlodipine, Chlorhexidine Base, Carbidopa, Enrofloxcin and Phthaloyl Amlodipine.

For the year ending March 2010, Smruthi Organics' total income touched Rs. 1269.78 million. Adding to it, the company's net profit stands at Rs. 55.49 million. Currently no analysts are following the stock.